UK NHS patient data transfer to US firm worries MPs and doctors

The transfer of NHS patient data to the control of a US private equity firm is causing serious concerns.

A £300 million deal involving the transfer of data from patients of the UK National Health Service (NHS) to a US private equity firm has led to calls for thorough scrutiny by doctors and members of parliament. This agreement is raising public questions regarding the possibility of placing critical NHS patient data under the management of a private company.

The main concerns are related to data privacy and the impact on the UK public health system. Critics emphasize the lack of clarity regarding the future consequences of personal health data falling into private hands, especially concerning data usage and protection mechanisms.

According to a report by "The Guardian", this deal is a significant financial move for the National Health Service and could have long-term strategic consequences. Healthcare professionals and politicians are calling for measures to increase the transparency of the agreement and to guarantee the security of patient data.